Mariner
NVCR icon

Mariner’s NovoCure NVCR Stock Holding History

Mariner’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Sell
17,595
-2,773
-14% -$34.6K ﹤0.01% 3175
2025
Q4 		$264K Sell
20,368
-3,182
-14% -$40.8K ﹤0.01% 2949
2025
Q3 		$304K Buy
23,550
+12,460
+112% +$166K ﹤0.01% 2794
2025
Q2 		$197K Sell
11,090
-1,651
-13% -$28.8K ﹤0.01% 3061
2025
Q1 		$227K Buy
12,741
+4,110
+48% +$93.3K ﹤0.01% 2891
2024
Q4 		$257K Buy
+8,631
New +$183K ﹤0.01% 2770
2023
Q1 		– Sell
-6,252
Closed -$459K – 2852
2022
Q4 		$459K Sell
6,252
-325
-5% -$24.5K ﹤0.01% 1705
2022
Q3 		$500K Buy
+6,577
New +$513K ﹤0.01% 1420

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Mariner's NVCR Position: Q1 2026 in Review

Mariner reduced its NovoCure (NVCR) stake by 14% in Q1 2026, selling an estimated $34.6K and leaving 17,595 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

Mariner first reported a position in NVCR in Q3 2022 and has held it in 8 quarters since. The position peaked at $500K in Q3 2022. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Mariner held 17,595 shares of NovoCure worth $192K as of Q1 2026.
  • Mariner sold 2,773 NovoCure shares in Q1 2026, an estimated $34.6K.
  • NovoCure made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3175 holding.
  • Mariner first reported a position in NovoCure in Q3 2022 and has held it in 8 quarters since.
  • Mariner's NovoCure position peaked at $500K in Q3 2022.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.